These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 610051)

  • 21. Biliary excretion of metabolites of 2-acetamidofluorene by mouse and guinea pig in vivo, and in isolated perfused rat liver.
    Miyata K; Noguchi Y; Enomoto M
    Jpn J Exp Med; 1972 Oct; 42(5):483-9. PubMed ID: 4539212
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatic uptake and biliary excretion of the neuroprotectant 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo-(F)-quinoxaline in rat liver. Involvement of an organic anion transport system.
    Hansen KT
    Biochem Pharmacol; 1995 Feb; 49(4):489-93. PubMed ID: 7872954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tilorone-induced lysosomal storage mimicking the features of mucopolysaccharidosis and of lipidosis in rat liver.
    Lüllmann-Rauch R
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1983; 44(3):355-68. PubMed ID: 6198800
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucopolysaccharidosis and lipidosis in rats treated with tilorone analogues.
    Hein L; Lüllmann-Rauch R
    Toxicology; 1989 Oct; 58(2):145-54. PubMed ID: 2508267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The tilorone-induced mucopolysaccharidosis in rats. Biochemical investigations.
    Prokopek M
    Biochem Pharmacol; 1991 Nov; 42(11):2187-91. PubMed ID: 1720315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimental encephalitis caused by herpes simplex virus: comparison of treatment with tilorone hydrochloride and phosphonoacetic acid.
    Fitzwilliam JF; Griffith JF
    J Infect Dis; 1976 Jun; 133 Suppl():A221-5. PubMed ID: 180204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat.
    Svensson CK; Knowlton PW
    Pharm Res; 1989 Jun; 6(6):477-80. PubMed ID: 2474808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposition of amphotericin B in the isolated perfused rat liver.
    Hong Y; Ramzan I; McLachlan AJ
    J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vitro and in vivo evaluation of tilorone hydrochloride as a platelet aggregation inhibitor.
    MacKenzie RD; Schatzman GL
    Scand J Haematol; 1975 Aug; 15(1):58-62. PubMed ID: 1179165
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunomodulation and drug acetylation: influence of the immunomodulator tilorone on hepatic, renal and blood N-acetyltransferase activity and on hepatic cytosolic acetyl coenzyme A content.
    Drobitch RK; Tomilo M; Svensson CK
    Biochem Pharmacol; 1992 Apr; 43(7):1643-8. PubMed ID: 1567485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of tilorone hydrochloride on graft-versus-host (GvH) reaction in mice.
    Zschiesche W; Slavina E; Leipunskaya I
    Acta Biol Med Ger; 1977; 36(1):107-12. PubMed ID: 17988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic and intestinal first-pass effects of oltipraz in rats.
    Bae SK; Kim JW; Kim YH; Kim YG; Kim SG; Lee MG
    Biopharm Drug Dispos; 2005 May; 26(4):129-34. PubMed ID: 15744718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous evaluation of intestinal absorption and hepatic extraction of 5-fluorouracil using portal-systemic concentration difference by short-period double dosing in a single conscious rat.
    Sawai Y; Yamaoka K; Ito T; Nakagawa T
    Biol Pharm Bull; 1997 Dec; 20(12):1313-6. PubMed ID: 9448112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant polyarthritis. II. Suppression by tilorone.
    Chang YH
    J Pharmacol Exp Ther; 1977 Oct; 203(1):156-61. PubMed ID: 909049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Distribution and disposition of trospectomycin sulfate in the in vivo rat, perfused rat liver, and cultured rat hepatocytes.
    Cox JW; Dring LG; Ginsberg LC; Larson PG; Constable DA; Ulrich RG
    Drug Metab Dispos; 1990; 18(5):726-31. PubMed ID: 1981727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Local absorption kinetics into the portal system using the portal-venous concentration difference after an oral dose of diclofenac in the awakening rat. Accelerative effect of bile on intestinal absorption of diclofenac.
    Tabata K; Yamaoka K; Fukuyama T; Nakagawa T
    Drug Metab Dispos; 1996 Feb; 24(2):216-20. PubMed ID: 8742234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Keratopathy after oral administration of tilorone hydrochloride.
    Weiss JN; Weinberg RS; Regelson W
    Am J Ophthalmol; 1980 Jan; 89(1):46-53. PubMed ID: 6243446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Moment analysis of stereoselective biliary excretion and chiral inversion of ketoprofen enantiomers in perfused rat liver.
    Yasui H; Yamaoka K; Dote N; Nakagawa T
    J Pharm Sci; 1995 Nov; 84(11):1327-31. PubMed ID: 8587051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of changes in hepatic disposition of phenolsulfonphthalein, indocyanine green and fluorescein isothiocyanate-dextran at low temperatures using a rat liver perfusion system.
    Miyamoto H; Miyake H; Yoshikawa N; Hirata H; Ohwaki Y; Fumoto S; Sasaki H; Nakamura J; Nishida K
    J Pharm Pharmacol; 2012 Jun; 64(6):848-54. PubMed ID: 22571263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.